Rezolute CFO Evans Makes Strategic Move: Buys Shares Worth $79,577
Introduction to Rezolute and Its CFO Rezolute, Inc. is a biotechnology firm that focuses on developing transformative therapeutics for patients dealing with serious and rare diseases. Established with the mission to address unmet medical needs, Rezolute employs innovative approaches and advanced technologies in its drug development initiatives. The company garnered attention in recent years due … Read more